SYSTEM AND METHOD FOR DYNAMIC DRUG INTERACTION ANALYSIS AND REPORTING

• US 20090254374A1
• Filed: 04/06/2009
• Published: 10/08/2009
• Est. Priority Date: 04/08/2008
• Status: Abandoned Application

• Current Assignee: Noel J. Guillama
• Original Assignee: Quantum Group Inc.
• Inventors: Martinez, Pedro, Guillama, Noel
• Application Number:
  US12/418,674
• Publication Number:
  US 20090254374A1
• Time in Patent Office: Days
• US Class Current: 705/3
• CPC Class Codes: G06Q 10/0635 Risk analysis of enterprise or organisation activities
• CPC Class Codes: G06Q 40/08 Insurance
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records
• CPC Class Codes: G16H 15/00 ICT specially adapted for medical reports, e.g. generation or transmission thereof
• CPC Class Codes: G16H 70/40 relating to drugs, e.g. their side effects or intended usage

Abstract

A system for capturing, synthesizing, analyzing, and reporting drug performance data. The system can comprise one or more electronic data processors and a data communications interface connected with the one or more processors for accessing a plurality of databases containing drug analysis and best-practice guidelines, patient data, and demographic data. The system can also include a situational modeler configured to execute on the electronic data processor in order to integrate the best-practice guidelines, patient data, and demographic data, create best-practice templates for analysis, based upon the integration of the guidelines, patient data, and demographic data, analyze the best-practice guidelines, patient data, and demographic data, and generate a series of reports and analyses to determine drug performance, based upon the analysis.

Claims

1. A computer-based method for capturing, synthesizing, analyzing, and reporting drug performance data, the method comprising:

accessing a plurality of databases containing drug analysis and best-practice guidelines, patient data, and demographic data;

integrating the best-practice guidelines, patient data, and demographic data;

creating best-practice templates for analysis, based upon the integration of the guidelines, patient data, and demographic data;

analyzing the best-practice guidelines, patient data, and demographic data; and

generating a series of reports and analyses to determine drug performance, based upon the analysis.

2. The method of claim 1, wherein the plurality of databases comprise at least one of a best-practice guidelines database, a patient database, and a demographic database;

and wherein the step of accessing comprises retrieving at least one of best-practice guidelines from the best-practice guidelines database, patient data from the patient database, and demographic data from the demographic database.

3. The method of claim 1, wherein said patient data are selected from at least one among doctor-patient data, hospital records, related care provider data and patient input.

4. The method of claim 1, wherein said best practice guidelines are selected from at least one among Food and Drug Administration guidelines, pharmaceutical guidelines, and industry reference data.

5. The method of claim 1, wherein the step of integrating said best-practice guidelines, said patient data, and said demographic data comprises using a situational modeler, wherein said situational modeler identifies which best-practice guidelines are to be used with a particular set of patient data and demographic data.

6. The method of claim 5, further comprising providing monitoring of drugs and real-time alerts identifying potential areas of concern.

7. The method of claim 1, wherein said reports and analyses comprise at least one of a drug usage report, trends analysis, potential concerns reports, advanced studies reports, expert analysis of data and reports, and drug interaction analysis reports.

8. A computer-based system for capturing, synthesizing, analyzing, and reporting drug performance data, the system comprising:

at least one electronic data processor;

a data communications interface connected with said processor for accessing a plurality of databases containing drug analysis and best-practice guidelines, patient data, and demographic data;

a situational modeler configured to execute on said electronic data processor, in which said situational modeler is configured to;

integrate the best-practice guidelines, patient data, and demographic data,

create best-practice templates for analysis, based upon the integration of the guidelines, patient data, and demographic data,

analyze the best-practice guidelines, patient data, and demographic data, and

generate a series of reports and analyses to determine drug performance, based upon the analysis.

9. The system of claim 8, wherein the plurality of databases comprise at least one of a best-practice guidelines database, a patient database, and a demographic database;

and wherein accessing comprises retrieving at least one of best-practice guidelines from the best-practice guidelines database, patient data from the patient database, and demographic data from the demographic database.

10. The system of claim 8, wherein said patient data are selected from at least one among doctor-patient data, hospital records, related care providers and patient input.

11. The system of claim 8, wherein said best practice guidelines are selected from at least one among Food and Drug Administration guidelines, pharmaceutical guidelines, and industry reference data.

12. The system of claim 8, wherein said situational modeler identifies which best-practice guidelines are to be used with a particular set of patient data and demographic data.

13. The system of claim 12, further comprising providing monitoring of drugs and real-time alerts identifying potential areas of concern.

14. The system of claim 8, wherein said reports and analyses comprise at least one of a drug usage report, trends analysis, potential concerns reports, advanced studies reports, expert analysis of data and reports, and drug interaction analysis reports.

15. A computer-readable storage medium having stored therein computer-readable instructions, which, when loaded in and executed by a computer causes the computer to perform the steps of:

accessing a plurality of databases containing drug analysis and best-practice guidelines, patient data, and demographic data;

integrating the best-practice guidelines, patient data, and demographic data;

creating best-practice templates for analysis, based upon the integration of the guidelines, patient data, and demographic data;

analyzing the best-practice guidelines, patient data, and demographic data; and

generating a series of reports and analyses to determine drug performance, based upon the analysis.

16. The computer-readable storage medium of claim 15, wherein the plurality of databases comprise at least one of a best-practice guidelines database, a patient database, and a demographic database;

and wherein the step of accessing comprises retrieving at least one of best-practice guidelines from the best-practice guidelines database, patient data from the patient database, and demographic data from the demographic database.

17. The computer-readable storage medium of claim 15, wherein said patient data are selected from at least one among doctor-patient data, hospital records, related care providers and patient input.

18. The computer-readable storage medium of claim 15, wherein said best practice guidelines are selected from at least one among Food and Drug Administration guidelines, pharmaceutical guidelines, and industry reference data.

19. The computer-readable storage medium of claim 15, further comprising code for causing the computer to provide monitoring of drugs and real-time alerts identifying potential areas of concern.

20. The computer-readable storage medium of claim 15, wherein said reports and analyses comprise at least one of a drug usage report, trends analysis, potential concerns reports, advanced studies reports, expert analysis of data and reports, and drug interaction analysis reports.